the lung thromboembolization was favoured by the cardiovascular affections ( 38.5 % ) , neurologic affections ( 27 % ) , malignant tumours ( 11.5 % ) , postsurgery status ( 9 % ) , lung diseases ( 9 % ) , coma ( 3.5 % ) , prostate affections ( 1.5 % ) .
C0024109
lung
C0024115
lung diseases